Company · CIK 1651625
AC Immune SA
| CIK | 1651625 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V8 |
| Business address | Switzerland |
| Listed | ACIU (Nasdaq) |
| First annual or quarterly report | 2017-03-17 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-277940 | 2024-03-14 | 2024-08-06 | 3 | |
| 333-255576 | 2021-04-28 | 2023-12-15 | 4 | |
| 333-227016 | 2018-08-24 | 2022-05-19 | 3 | |
| 333-249655 | 2020-10-23 | 2020-11-05 | 2 | |
| 333-224694 | 2018-05-04 | 2020-09-08 | 6 | |
| 333-211714 | 2016-05-31 | 2016-09-23 | 10 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-08-06 | 424B5Shelf takedown | 333-277940 | 0000950103-24-011782 |
| 2024-07-31 | EFFECTDeclared effective | 333-277940 | 9999999995-24-002330 |
| 2024-03-14 | F-3Shelf registered | 333-277940 | 0000950103-24-003853 |
| 2023-12-15 | 424B5Shelf takedown | 333-255576 | 0000950103-23-017553 |
| 2022-05-19 | 424B5Shelf takedown | 333-227016 | 0000950103-22-008805 |
| 2021-05-05 | EFFECTDeclared effective | 333-255576 | 9999999995-21-001806 |
| 2021-05-05 | 424B5Shelf takedown | 333-255576 | 0000950103-21-006776 |
| 2021-04-28 | F-3Shelf registered | 333-255576 | 0000950103-21-006233 |
| 2020-11-05 | EFFECTDeclared effective | 333-249655 | 9999999995-20-003091 |
| 2020-10-23 | F-3Shelf registered | 333-249655 | 0000950103-20-020540 |
| 2020-09-08 | 424B5Shelf takedown | 333-224694 | 0000950103-20-017578 |
| 2018-09-07 | EFFECTDeclared effective | 333-227016 | 9999999995-18-002309 |
| 2018-08-24 | F-3Shelf registered | 333-227016 | 0000950103-18-009949 |
| 2018-07-20 | 424B5Shelf takedown | 333-224694 | 0000950103-18-008705 |
| 2018-07-19 | 424B5Shelf takedown | 333-224694 | 0000950103-18-008673 |
| 2018-07-17 | 424B5Shelf takedown | 333-224694 | 0000950103-18-008583 |
| 2018-06-08 | EFFECTDeclared effective | 333-224694 | 9999999995-18-001454 |
| 2018-05-04 | F-3Shelf registered | 333-224694 | 0000950103-18-005925 |
| 2016-09-23 | 424B4Final prospectus | 333-211714 | 0001193125-16-718500 |
| 2016-09-22 | EFFECTDeclared effective | 333-211714 | 9999999995-16-005750 |
| 2016-09-22 | F-1/AAmendment | 333-211714 | 0001193125-16-716813 |
| 2016-09-21 | F-1/AAmendment | 333-211714 | 0001193125-16-715981 |
| 2016-09-16 | F-1/AAmendment | 333-211714 | 0001193125-16-711781 |
| 2016-09-13 | F-1/AAmendment | 333-211714 | 0001193125-16-708561 |
| 2016-09-07 | F-1/AAmendment | 333-211714 | 0001193125-16-702253 |
| 2016-07-11 | F-1/AAmendment | 333-211714 | 0001193125-16-645087 |
| 2016-06-15 | F-1/AAmendment | 333-211714 | 0001193125-16-622656 |
| 2016-05-31 | F-1Registration filed | 333-211714 | 0001193125-16-607922 |
| 2015-08-28 | DRSDraft made public | 377-01130 | 0000950123-15-009640 |